CDK4/6 Inhibitors in Breast Cancer—Who Should Receive Them? is a research paper published in International Journal of Molecular Sciences (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH
Grant: P50CA186784-06
DoD
Grant: W81XWH-21-1-0106
DoD
Grant: W81XWH-21-1-0634
DoD
Grant: HT94252410103
NIH HHS
Grant: 1P50CA186784-05
NIH HHS
Grant: P50CA186784
FWCI
1.43
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords